Dermatology: Practical and Conceptual Original Article | Dermatol Pract Concept. 2024;14(4):4566 1 Correlation of Psychosomatic Factors and Personality Traits with The Severity of Hidradenitis Suppurativa Konstantinos Kontoangelos1,2, Foteini Dionysia Foulou1, Sofia Tsiori1, Charalabos Papageorgiou2, Alexander Stratigos3, Aikaterini I Liakou3 1 1st Department of Psychiatry, Eginition Hospital, Medical School National & Kapodistrian University of Athens, Greece 2 University Mental Health Neurosciences and Precision Medicine Research Institute “Costas Stefanis”, Greece 3 1st Dermatology Department, Andreas Syggros Hospital for Skin Diseases, National & Kapodistrian University of Athens, Greece Key words: Factitious disorder, Depression, Psychosomatic, Pain, Psychodermatology Citation: Kontoangelos K, Foulou FD, Tsiori S, Papageorgiou C, Stratigos A, Liakou AI. Correlation Of Psychosomatic Factors And Personality Traits With The Severity Of Hidradenitis Suppurativa. Dermatol Pract Concept. 2024;14(4):4566. DOI: https://doi. org/10.5826/dpc.1404a4566 Accepted: June 7, 2024; Published: January 2025 Copyright: ©2024 Kontoangelos et al. This is an open-access article distributed under the terms of the Creative Commons Attribution- NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing Interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding Author: Konstantinos Kontoangelos, Athens University Medical School, 1st Department of Psychiatry, Eginition Hospital, 74 Vasilissis Sofias Avenue, 11528, Athens, Greece; Phone: 0030-210-7289218; E-mail: kontoangel@med.uoa.gr Introduction: Hidradenitis suppurativa is a disease with a decisive burden on sufferers, both physical and psychological. It was expected that the more intense the severity of symptoms the patients experi- enced, the greater the correlation with the psychosomatic manifestations would be. Objectives: The present study aimed to explore the correlation between hidradenitis suppurativa and the psychosomatic burden, the personality, and the demographic characteristics of the participants. Methods: The participants were 90 outpatients of the hospital, aged 18 to 65, who had been di- agnosed with hidradenitis and were sufficiently proficient in Greek. The psychometric instruments administered were the Symptom Checklist-90 (SCL90), the Beck Depression Inventory (BDI), the Ey- senck Personality Questionnaire (EPQ), the short-form McGill Pain Questionnaire (SF-MPQ), the Hurley and refined Hurley classifications, the International Hidradenitis Suppurativa Severity Scoring System (IHS4), and a short demographic questionnaire. All statistical analyses were performed using the SPSS-28 statistical package. Results: According to statistical analyses, there was no statistically significant relationship between disease severity, psychosomatic burden, and personality. However, there were statistically significant associations with demographic factors, such as being female or not being in a relationship, the patient’s ABSTRACT 2 Original Article | Dermatol Pract Concept. 2024;14(4):4566 Introduction The human body as a whole is covered by the skin, thus making it the most visible organ of the body. Therefore, any problem that appears on the skin can potentially affect the mental health of the person [1]. One of the diseases that cause intense skin changes and that have been linked to a multitude of mental disorders is hidradenitis suppurativa (HS) [2]. Undoubtedly, based on the international literature, the most frequently studied aspect of diffuse hidradenitis is the positive correlation between anxiety and depression in patients [3]. Patients with HS present high rates of psy- chopathology which are related to the nature of the disease (the intense pain and the foul-smelling secretions that make the person’s daily life difficult), as a result of which they refrain from their activities and are gradually led to isola- tion, which by definition is a risk factor for depression [4,5]. Psychosocial vulnerability in HS patients is related to the psychological disability and financial burden it creates, in addition to physical problems [6], and HS patients also dis- play a significantly inferior quality of life as well as worse anxiety and depression symptomatology when compared to patients with alopecia, mild-to-moderate psoriasis, and various other dermatological diseases [7-9]. Apart from the brain-skin connection, in the literature there are reports of common behavioral habits (e.g., smoking) among those suffering from HS and mental disorders [10-12]. Another common behavior of HS and mental illness sufferers is sub- stance abuse and alcohol consumption. Patients with HS commonly use cannabis, opioids, and alcohol in order to reduce the anxiety or the pain they experience as a result of the disease [13]. In the literature, there is a connection between dermatological diseases and obsessive-compulsive disorder [14]. A possible explanation given by the research- ers is that people who suffer from obsessive-compulsive disorder, compared to the general population, visit health professionals more often, as a result of which they receive more diagnoses in all diseases, therefore also in dermatolog- ical ones [15,16]. Another important element that burdens the psychology of patients with HS is pain [17,18]. Chronic pain usually occurs in people with an advanced stage of the disease, and the sensation is described as pulsating, creating heightened sensitivity [19,20]. Objectives In the present study, the correlation between the severity of hidradenitis suppurativa and psychosomatic burden with personality and pain was investigated. Whether demographic factors correlate with psychopathological manifestations and personality traits was also examined. Methods The sample of the study included outpatients of the Andreas Syggros Hospital who had received a diagnosis of hidrade- nitis suppurativa (HS). More specifically, 90 patients with HS participated; the majority were males (N=48), making up 53.3% of the total, compared to females (N=42), who formed the remaining 46.7%. In terms of the age distri- bution, the participants ranged in age from 18 to 65 years old. The range of age at disease onset was from two to 43, with a mean value of 12.6 years, and in 77.7% of partic- ipants (N=70), there was a large discrepancy between the date of onset of the disease and the date of diagnosis. In fact, 71.1% (N=64) had visited several medical specialties, such as general surgeons, plastic surgeons, gynecologists, and dermatologists, before they received the correct diagno- sis. Additionally, regarding the site part of the physical dam- age, the majority had genital damage (N=72) at a percentage of 80.0%, while 43.3% (ν=39) had damages in the anus or buttocks (N=39), 13.5% in inframammary fold, and only 5.6% (N=5) showing the disease on the face; 100% of the sample had at least two foci of infection from the disease. When the assessment was performed, 48.8% (N=44) scored Hurley II on the severity scale, 31.1% (N=28) had Hurley III, and 20% (N=18) had Hurley I. Regarding co-morbidity, only 40.0% (N=36) had accompanying diseases simultane- ously to hidradenitis. Also, a minority of the patients had a psychiatric history at a rate of 26.7% (N=24), of which the most frequently occurring mental disorders were depression (N=16) and symptoms of anxiety (N=5). Research Process The questionnaires were completed anonymously. The par- ticipants were informed about the purposes of the study and body mass index, the locus of the skin lesion, a history of hospitalization, comorbidities, psychiatric history, and pain with psychopathological manifestations and personality. Conclusions: It is important that further research be conducted that will include more mental disor- ders besides anxiety and depression while at the same time excluding confounding factors for safer interpretation of the results. Original Article | Dermatol Pract Concept. 2024;14(4):4566 3 Table 1. Descriptive Characteristics and Reliability Coefficients for BDI, SCL90, and EPQ. Psychometric scales Mean SD Minimum Maximum Cronbach’s Alpha BDI 13.10 10.99 0 46 0.93 SCL90 Somatization 0.76 0.98 0 4 0.95 Obsessive-compulsive 0.00 0.00 0 0 0.97 Interpersonal sensitivity 0.00 0.00 0 0 0.95 Depression 15.48 11.15 0 42 0.97 Anxiety 8.77 7.59 0 29 0.95 Hostility 5.53 4.89 0 23 0.85 Phobic anxiety 3.39 5.08 0 20 0.97 Paranoid ideation 4.83 4.71 0 20 0.90 Psychoticism 5.18 5.98 0 24 0.85 EPQ Psychoticism 4.62 2.40 1 12 0.70 Neuroticism 12.12 5.72 1 22 0.81 Extraversion 12.52 4.60 1 19 0.81 Lying Lie 9.44 4.02 1 18 0.65 Abbreviations: Mean: mean value, SD: standard deviation, Min: minimum, Max: maximum, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL-90: Symptom Checklist their participation was voluntary, while at the same time an- onymity and confidentiality were respected. The entire pro- cess was entirely governed by the principles of the Code of Ethics & Conduct. Means of Data Collection Brief Demographic Information Questionnaire: Information was requested regarding age, sex, weight, smoking, employ- ment, education level, marital status, number of children, place of birth origin, place of residence, co-morbidity with other diseases, date of disease onset, date of diagnosis, the medical specialties visited, the part of the body where there was a skin lesion, the treatment they had received for hi- dradenitis, the existence of hospitalization for the disease, the Hurley, refined Hurley, and International  Hidradenitis Suppurativa Severity Scoring System (IHS4) scores, the ex- istence of psychiatric history, diagnosis, taking medication, and whether they were undergoing psychotherapy. The Symptom Checklist-90 (SCL-90) [21] is a self- completed questionnaire that measures nine psychopathol- ogy parameters (as many as its subscales): (1) somatization; (2) depression; (3) anxiety; (4) phobic anxiety; (5) obsessive compulsive; (6) paranoid ideation; (7) psychoticism; (8) hos- tility; (9) interpersonal sensitivity. The questionnaire includes a total of 90 questions [22]. The Beck Depression Inventory (BDI) is a 21-question multiple-choice self-assessment report inventory, one of the most widely used instruments for measuring the severity of depression. Its development marked a shift among health- care professionals, who had until then viewed depression from a psychodynamic perspective, instead of it being rooted in the patient’s own thoughts [23]. The Eysenck Personality Questionnaire (EPQ) [24] is a psychometric personality scale that consists of 84 items eval- uated by the patient with a yes or no answer. The purpose of this questionnaire is to explore four dimensions of personal- ity: psychoticism (P), neuroticism (N) extraversion (E), and lying (L) [25]. The main component of the short-form McGill Pain Questionnaire (SF-MPQ) consists of 15 descriptors (11 sen- sory; four 4 affective) which are rated on an intensity scale as 0 = none, 1 = mild, 2 = moderate, or 3 = severe. Three pain scores are derived from the sum of the intensity rank values of the words chosen for sensory, affective, and total descriptors [26]. In order to calculate the severity of (HS), dermatologists evaluate patients with three scales: Hurley, refined Hurley, and IHS4. The Hurley scale consists of three subtypes (I, II, and III) [27]. Finally, the IHS4 is a validated tool for the dynamic assessment of HS severity, correlates with the Hur- ley classification, and can be used both in real life and in a clinical trial setting [28]. Statistical Analysis The descriptive characteristics and Cronbach’s alpha mea- sure of the psychometric tools are presented in Table 1, where most of the scales have excellent or good reliability level, whereas only the scale of psychoticism and lying lie of the personality questionnaire have acceptable or question- able levels. 4 Original Article | Dermatol Pract Concept. 2024;14(4):4566 higher scores on the scales of interpersonal sensitivity (mean: 8.29, SD: 8.06 and mean: 8.91, SD: 7.26 vs. mean: 4.48, SD: 4.18, P = 0.031) and of paranoid ideation (mean: 5.39, SD: 4.39 and mean: 5.79, SD: 5.90 vs. mean: 2.28, SD: 1.95, P = 0.024). Patients who had lesions in the armpit had statisti- cally significantly more extroversion symptoms compared to patients who did not have physical lesions in the arm- pit (mean: 13.79, SD: 4.64 vs. mean: 11.42, SD: 4.32, P = 0.008, Table 5). On the other hand, patients who had damage to the anus or buttocks had on average a statis- tically significantly lower score on the extraversion scale than patients who did not have damage on anus or but- tocks (mean: 11.15, SD: 4.75 vs. mean: 13.57, SD: 4.24, P = 0.017, Table 6). Hospitalized patients had a statistically significantly lower score on the BDI depression scale (mean: 6.09, SD: 7.16 vs. mean: 14.08, SD: 11.10, P = 0.011), of soma- tization (mean: 4.09, SD: 5.26 vs. mean: 9.87, SD: 9.71, P = 0.031), of interpersonal sensitivity (mean: 3.73, SD: 3.41 vs. mean: 7.99, SD: 7.28, P = 0.045), SCL90 depression (mean: 8.27, SD: 7.48 vs. mean: 15.00, SD: 11.13, P = 0.041), and neuroticism (mean: 8.36, SD: 5.78 vs. mean: 12.65, SD: 5.55, P = 0.020), and higher scores on the extroversion Comparing the psychometric scales with the sex of the patients, it turns out that females diagnosed with hidradenitis had on average a higher score than did males in a multitude of variables. More specifically, females scored on average statistically significantly higher than males in BDI (mean: 16.17, SD: 12.20 vs. mean: 10.42, SD: 9.11, P = 0.020), in somatization (mean: 12.40, SD: 10.04 vs. mean: 6.33, SD: 7.98, P = 0.002), in obsessive-compulsive (mean: 12.38, SD: 9.26 vs. mean: 8.31. SD: 6.54, P = 0.046), in the in- terpersonal sensitivity (mean: 9.81, SD: 8.59 vs. mean: 5.42 SD: 4.54, P = 0.018), in depression (mean: 17.55, SD: 12.59 vs. mean: 11.23, SD: 8.33, P = 0.032), in anxiety (mean: 9.98, SD: 8.99 vs. mean: 5.25, SD: 4.76, P = 0.040), and in pho- bic anxiety (mean: 4.60, SD: 6.17 vs. mean: 1.29, SD: 2.20, P = 0.002). The results are given in Table 2. Moreover, it was examined whether family structure cor- related with psychopathological symptoms and personality. Patients who were without a partner (either single, divorced, or widowed) had on average a statistically significantly higher score on the anxiety scale compared to the patients who were married or under cohabitation agreement (mean: 8.00, SD: 7.02 vs. mean: 6.37, SD: 7.83, P = 0.046, Table 3). According to Table 4, patients who were overweight or obese compared to patients with a normal weight had Table 2. Mean, Standard Deviation of the Psychometric Scales by Patient Sex. Psychometric scales Sex  U-value P Male Female Mean SD Mean SD BDI BDI 10.42 9.11 16.17 12.20 720.00 0.020 SCL90 Somatization 6.33 7.98 12.40 10.04 626.50 0.002 Obsessive- compulsive 8.31 6.54 12.38 9.26 761.50 0.046 Interpersonal sensitivity 5.42 4.54 9.81 8.59 715.50 0.018 Depression 11.23 8.33 17.55 12.59 743.50 0.032 Anxiety 5.25 4.76 9.98 8.99 754.50 0.040 Hostility 4.35 4.48 5.02 5.39 968.50 0.747 Phobic anxiety 1.29 2.20 4.60 6.17 650.00 0.002 Paranoid ideation 3.69 3.26 5.81 5.88 873.50 0.273 Psychoticism 3.65 4.57 6.62 6.92 782.50 0.066 EPQ Psychoticism 4.52 2.25 4.74 2.59 989.50 0.880 Neuroticism 11.25 5.93 13.12 5.37 845.00 0.186 Extraversion Introversion 13.13 4.52 11.83 4.65 844.00 0.183 Lying Lie 8.92 3.74 10.05 4.29 847.50 0.192 Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90. Original Article | Dermatol Pract Concept. 2024;14(4):4566 5 Table 3. Mean, Standard Deviation of the Psychometric Scales by the Patients’ Family Status. Psychometric scales Family status U-value P Not married/Divorced/ Widowed Married/Cohabitation agreement Mean SD Mean SD BDI 13.70 11.77 12.19 9.79 946.00 0.830 SCL90 Somatization 7.70 7.65 9.60 10.57 722.00 0.758 Obsessive compulsive 10.00 7.68 9.89 8.11 723.00 0.767 Interpersonal sensitivity 7.70 6.97 6.80 6.91 651.00 0.306 Depression 13.35 9.32 13.91 11.43 722.00 0.759 Anxiety 8.00 7.02 6.37 7.83 554.50 0.046 Hostility 4.42 3.64 5.06 6.36 687.50 0.510 Phobic anxiety 3.40 4.95 2.37 4.91 583.50 0.074 Paranoid ideation 4.26 4.35 4.77 4.89 721.00 0.750 Psychoticism 4.84 5.39 4.74 5.91 691.00 0.533 EPQ Psychoticism 4.78 2.60 4.39 2.09 927.00 0.708 Neuroticism 12.15 6.07 12.08 5.24 966.00 0.961 Extraversion Introversion 12.56 4.99 12.47 4.01 934.00 0.754 Lying Lie 9.35 4.37 9.58 3.50 924.50 0.694 Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory ; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90. Table 4. Mean, Standard Deviation of the Psychometric Scales by Patients’ Body Mass Index. Psychometric scales Body Mass Index   P Normal Overweight Obese Mean SD Mean SD Mean SD Kruskal- Wallis H BDI 8.92 7.91 15.39 12.97 14.09 10.39 4.59 0.101 SCL90 Somatization 6.08 6.42 10.58 10.44 10.15 10.10 2.98 0.226 Obsessive compulsive 6.92 4.75 10.81 9.57 12.09 8.17 5.25 0.073 Interpersonal sensitivity 4.48 4.18 8.29 8.06 8.91 7.26 6.97 0.031 Depression 10.00 7.23 15.42 11.89 16.12 11.74 4.20 0.123 Anxiety 5.12 4.64 7.61 7.86 9.03 8.34 2.55 0.279 Hostility 3.12 3.37 4.00 3.55 6.41 6.31 4.46 0.108 Phobic anxiety 1.88 3.79 3.13 5.40 3.26 4.86 2.32 0.313 Paranoid ideation 2.28 1.95 5.39 4.39 5.79 5.90 7.49 0.024 Psychoticism 2.64 3.49 6.06 7.03 5.85 5.96 4.99 0.083 EPQ Psychoticism 4.76 2.92 4.52 2.50 4.62 1.91 0.25 0.882 Neuroticism 10.36 4.66 13.03 6.00 12.59 6.03 4.41 0.110 Extraversion 13.48 3.03 12.55 5.21 11.79 4.95 1.38 0.501 Lying Lie 9.80 3.67 8.81 3.68 9.76 4.57 1.20 0.550 Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist. 6 Original Article | Dermatol Pract Concept. 2024;14(4):4566 Table 5. Means Standard Deviation of the Psychometric Scales by Damage in Axilla. Psychometric scales Axilla U-value P No Yes Mean SD Mean SD BDI 13.38 10.97 12.79 11.13 953.50 0.659 SCL90 Somatization 9.19 10.00 9.14 8.92 968.00 0.746 Obsessive- compulsive 9.94 8.51 10.52 7.79 933.50 0.546 Interpersonal sensitivity 7.44 7.72 7.50 6.29 912.50 0.438 Depression 14.88 11.19 13.38 10.73 950.00 0.639 Anxiety 7.33 7.95 7.60 6.83 905.50 0.406 Hostility 4.19 5.02 5.21 4.78 824.00 0.133 Phobic anxiety 3.19 5.58 2.43 3.69 965.50 0.717 Paranoid ideation 4.44 4.88 4.95 4.67 886.50 0.322 Psychoticism 4.94 6.34 5.14 5.53 915.00 0.448 EPQ Psychoticism 4.23 2.38 5.07 2.37 779.00 0.061 Neuroticism 12.67 5.31 11.50 6.17 915.00 0.451 Extraversion 11.42 4.32 13.79 4.64 683.00 0.008 Lying Lie 9.79 3.72 9.05 4.36 904.00 0.398 Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90 Psychopathology Questionnaire. Table 6. Means Standard Deviation of the Psychometric Scales by Damage in Anus or Buttocks. Psychometric scales Anus / buttocks U-value P No Yes Mean SD Mean SD BDI 11.98 10.00 14.56 12.14 883.50 0.365 SCL90 Somatization Obsessive-compulsive 9.45 8.50 8.79 10.68 872.00 0.317 Interpersonal sensitivity 9.90 6.77 10.62 9.73 961.50 0.788 Depression 6.76 6.18 8.38 8.04 906.00 0.470 Anxiety 13.31 10.29 15.31 11.77 906.00 0.471 Hostility 7.71 6.85 7.13 8.16 878.00 0.341 Phobic anxiety 4.69 4.62 4.64 5.32 939.00 0.648 Paranoid ideation 2.76 4.11 2.92 5.59 909.00 0.463 Psychoticism 4.18 4.13 5.33 5.47 899.00 0.434 EPQ Psychoticism 4.67 2.16 4.56 2.71 936.50 0.633 Neuroticism 11.41 5.84 13.05 5.50 828.50 0.176 Extraversion 13.57 4.24 11.15 4.75 703.00 0.017 Lying Lie 9.63 4.15 9.21 3.89 924.00 0.564 Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck;s Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90 Psychopathology Questionnaire. scale (mean: 16.27, SD: 1.85 vs. mean: 12.00, SD: 4.63, P =0.002, Table 7). Patients who had comorbidities had on average statisti- cally significantly higher scores on the obsessive-compulsive scale (mean: 12.58, SD: 8.75 vs. mean: 8.63, SD: 7.37, P = 0.018), of paranoid ideation (mean: 6.22, SD: 5.66 vs. mean: 3.65, SD: 3.77, P = 0.037), and psychoticism (mean: 6.53, SD: 6.46 vs. mean: 4.04, SD: 5.41, P = 0.020, Table 8). Original Article | Dermatol Pract Concept. 2024;14(4):4566 7 scales. Regarding the personality scales, patients with a psy- chiatric history scored statistically significantly higher on the scale of psychoticism (mean: 5.75, SD: 2.47 vs. mean: 4.21, SD :2.26, P = 0.007) and neuroticism (mean: 15.58, SD: 5.67 vs. mean: 10.86, SD: 5.23, P <0.001), while scor- ing statistically significantly lower on the extraversion The existence of a psychiatric history in patients suffer- ing from hidradenitis affected most psychiatric scales. Pa- tients with a psychiatric history had statistically significantly higher scores on the BDI scale compared to those without a psychiatric history (mean: 22.96, SD: 13.24 vs. mean: 9.52, SD: 7.37, P <0.001) and in all SCL90 psychopathology Table 7. Means, Standard Deviation of the Psychometric Scales by Patient Hospitalization. Psychometric scales Hospitalization for hidradenitis  U-value P No Yes Mean SD Mean SD BDI 14.08 11.10 6.09 7.16 229.00 0.011 SCL90 Somatization 9.87 9.71 4.09 5.26 260.00 0.031 Obsessive compulsive 10.72 8.27 6.55 6.27 299.00 0.095 Interpersonal sensitivity 7.99 7.28 3.73 3.41 274.50 0.048 Depression 15.00 11.13 8.27 7.48 269.00 0.041 Anxiety 7.87 7.73 4.45 3.39 353.00 0.314 Hostility 4.78 5.06 3.82 3.74 393.50 0.610 Phobic anxiety 3.13 5.02 0.73 1.19 309.00 0.103 Paranoid ideation 5.01 4.92 2.27 2.33 290.50 0.074 Psychoticism 5.38 6.11 2.55 3.96 285.00 0.063 EPQ Psychoticism 4.61 2.46 4.73 2.05 402.50 0.690 Neuroticism 12.65 5.55 8.36 5.78 246.00 0.020 Extraversion 12.00 4.63 16.27 1.85 186.50 0.002 Lying Lie 9.23 3.90 11.00 4.71 330.00 0.196 Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90. Table 8. Means, Standard Deviation of the psychometric scales by the existence of comorbidities. Psychometric scales Comorbidities U-Value P No Yes Mean SD Mean SD BDI 11.69 9.80 15.22 12.41 807.00 0.173 SCL90 Somatization 7.89 8.86 11.08 10.10 780.50 0.114 Obsessive compulsive 8.63 7.37 12.58 8.75 686.50 0.018 Interpersonal sensitivity 6.33 5.97 9.17 8.22 759.50 0.079 Depression 12.76 10.44 16.31 11.47 788.50 0.130 Anxiety 6.83 7.09 8.39 7.87 821.50 0.214 Hostility 3.96 4.00 5.72 5.92 821.00 0.209 Phobic anxiety 2.44 3.96 3.42 5.81 928.00 0.703 Paranoid ideation 3.65 3.77 6.22 5.66 720.00 0.037 Psychoticism 4.04 5.41 6.53 6.46 691.50 0.020 EPQ Psychoticism 4.37 2.40 5.00 2.39 815.00 0.191 Neuroticism 11.87 5.65 12.50 5.89 905.50 0.583 Extraversion 12.43 4.58 12.67 4.69 942.00 0.804 Lying Lie 9.76 3.78 8.97 4.37 873.00 0.413 Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90. 8 Original Article | Dermatol Pract Concept. 2024;14(4):4566 to the existing literature. As was expected, the more severe damage the sufferers had (Hurley III), the higher their score in psychosomatic disorders [29,30]. A possible explanation for this finding is that the patients’ mental state seemed to be affected more by the perception they had of the disease and the consequences it would have on their lives than by the se- verity of the disease itself, as reflected by the dermatologists’ Hurley, defined Hurley, and IHS4 scales [31]. The statistical analysis showed that females were more burdened with depression, interpersonal sensitivity, anxiety, phobic anxiety, somatization, and compulsiveness. It appears that females suffering from HS show more frequent symp- toms of anxiety and depression [32,33]. However, in a more recent study [34], there were no differences between the two sexes in terms of psychopathological manifestations. Regarding body mass index, it was found that overweight and obese patients, in contrast with normal weight patients, had statistically significantly higher scores on the scales of interpersonal sensitivity and paranoid ideation. One possible explanation for the association with interpersonal sensitivity and paranoid ideation may be the constant recommendation by dermatologists to lose weight, as obesity is one of the main factors that negatively affects the progression of the disease [35], while it may also be a causative factor [36]. Additionally, the part of the body where the patients showed skin damage was correlated with the extraversion variable in the personality scale. Lesions in the armpit were associated with higher extraversion scores, while, on the contrary, those scale (mean: 10.58, SD: 5.41 vs. mean: 13.23, SD: 4.09, P = 0.029, Table 9). The correlation between patients’ psychometric scales and their age, the age at onset of the disease, the duration of the disease, and the pain scale are presented in Table 10. The pain scale seemed to influence the scores of the patients on the psychometric scales, since the BDI scale of depression is statistically significantly related with a positive correlation coefficient with the pain scale (r=0.65, P <0.001). The pain scale is statistically significantly related to the scales of soma- tization (r=0.32, P = 0.002), obsessive compulsive (r=0.26, P = 0.014), interpersonal sensitivity (r=0.43, P <0.001), de- pression (r=0.50, P <0.001), anxiety (r=0.31, P = 0.003), pho- bic anxiety (r=0.32, P = 0.002), paranoid ideation (r=0.35, P = 0.001), and psychoticism (r=0.37, P <0.001) with positive correlation coefficients. Therefore, patients who experienced more pain also scored higher on the corresponding scales. In addition, the pain scale was statistically significantly related to the neuroticism scale (r=0.46, P <0.001, Table 10). Discussion The purpose of the present study was to investigate the correlation between psychosomatic parameters, person- ality, and demographic data and the severity of hidradeni- tis suppurativa. As can be seen from the results, there was no correlation between the severity of the disease and the psychosomatic manifestations. This correlation is contrary Table 9. Means, Standard Deviation of the Psychometric Scales by the Psychiatric History. Psychometric scales Psychiatric history U-Value P No Yes Mean SD Mean SD BDI 9.52 7.37 22.96 13.24 318.00 <0.001 SCL90 Somatization 6.68 6.98 16.00 11.90 413.50 0.001 Obsessive compulsive 7.82 5.77 16.79 10.03 368.50 <0.001 Interpersonal sensitivity 5.20 4.27 13.71 9.24 347.00 <0.001 Depression 10.86 7.85 23.29 13.07 364.00 <0.001 Anxiety 4.92 4.54 14.42 9.23 335.50 <0.001 Hostility 3.68 3.80 7.38 6.47 522.50 0.013 Phobic anxiety 1.18 1.75 7.38 7.09 357.00 <0.001 Paranoid ideation 3.29 3.60 8.50 5.51 357.00 <0.001 Psychoticism 3.17 3.47 10.17 8.08 357.00 <0.001 EPQ Psychoticism 4.21 2.26 5.75 2.47 500.00 0.007 Neuroticism 10.86 5.23 15.58 5.67 407.00 <0.001 Extraversion 13.23 4.09 10.58 5.41 554.00 0.029 Lying Lie 9.58 3.65 9.08 4.99 723.50 0.530 Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90 Psychopathology Questionnaire. Original Article | Dermatol Pract Concept. 2024;14(4):4566 9 extraversion variable. From this analysis it appears that psychiatric history was perhaps a variable with the highest statistically significant correlations in the psychosomatic burden and in the personality scale, which can significantly increase the possibility that someone will develop a mental disorder [40]. It is worth noting that the question that the participants were asked was whether they had a psychiatric history, without specifying whether it predated the disease or whether it appeared due to the burden of the disease. In any case, the mental state of the sufferers should be assessed, and they should receive appropriate help immediately. Further- more, the psychiatric history variable positively correlated with the personality psychoticism scale, which, accord- ing to the developers of the EPQ, measures obsessive- compulsiveness and neuroticism similar to histrionic per- sonality. This could be because there is a high comorbidity between dermatological disorders and obsessive- compulsive personality, regardless of age for both sexes [15]. Additionally, the pain scale correlated statistically signifi- cantly with depression, anxiety, anger, paranoid ideation, psy- choticism, and the neuroticism variable from the personality scale. Based on the literature, it was expected that the longer the time between the date of onset and the age at diagnosis of the disease, the greater the burden on the patients would be, because they would have symptoms of hidradenitis without knowing what diseases they had nor would they have received with genital, anal, or gluteal lesions had a significantly lower score on the extraversion scale. At the same time, no differ- ences were observed in those with lower mammary lesions. This may be because having damage to the genitals and anus can result in avoidance of sexual contact. Even the damaged area, in combination with a wrong diagnosis by specialists, can be misinterpreted as a sexually transmitted disease, with the result that these individuals are isolated from interac- tions, experiencing fear and social stigmatization [37], and also because skin damage is accompanied by a strong odor, which further complicates everyday life [38]. Significant connections were also found with patients who had comorbidities. These people showed higher scores on the obsessive-compulsive, paranoid ideation, and psy- choticism scales. The connection between obsessive compul- sive disorder and individuals experiencing various organic diseases is well known, as is the emphasis patients place on physical changes, psychologically exhausting themselves by repeatedly visiting doctors and receiving more diagnoses of all diseases in comparison with the general population [15]. Moreover, endocrine disorders, in addition to anxiety and depression, have also been positively associated with psy- chotic symptoms [39]. Psychiatric history was also exam- ined, which appeared to be positively correlated with all variables of psychosomatic burden, psychoticism, and neu- roticism, while there was a negative correlation with the Table 10. Spearman Correlation Coefficient between the Psychometric Scales and Patients’ Age, the Age at Onset of the Disease, the Duration of the Disease, and the Pain Scale. Age Age at the onset of disease Duration of the disease Pain Cor. Coef. p Cor. Coef. p Cor. Coef. p Cor. Coef. P BDI 0.04 0.69 -0.02 0.876 -0.08 0.468 0.65 <0.001 SCL90 Somatization 0.06 0.587 -0.002 0.982 0.13 0.236 0.32 0.002 Obsessive compulsive -0.04 0.700 0.06 0.549 0.05 0.614 0.26 0.014 Interpersonal sensitivity -0.10 0.350 -0.06 0.602 -0.02 0.873 0.43 <0.001 Depression 0.002 0.986 0.02 0.864 -0.05 0.656 0.50 <0.001 Anxiety -0.06 0.598 0.07 0.512 -0.04 0.704 0.31 0.003 Hostility -0.04 0.726 0.01 0.945 0.02 0.869 0.13 0.220 Phobic anxiety -0.18 0.083 -0.08 0.473 -0.09 0.381 0.32 0.002 Paranoid ideation 0.08 0.485 0.03 0.811 0.02 0.886 0.35 0.001 Psychoticism -0.09 0.382 -0.06 0.608 0.03 0.773 0.37 <0.001 EPQ Psychoticism 0.10 0.375 0.03 0.763 0.09 0.419 0.10 0.368 Neuroticism 0.02 0.846 0.07 0.545 0.02 0.850 0.46 <0.001 Extraversion 0.04 0.688 -0.04 0.747 0.10 0.359 -0.15 0.159 Lying Lie 0.002 0.984 0.01 0.914 -0.01 0.961 -0.20 0.062 Abbreviations: Mean: mean value, SD: standard deviation, BDI: Beck Depression Inventory; EPQ: Eysenck Personality Questionnaire; SCL90: Symptom Checklist-90 Psychopathology Questionnaire. 10 Original Article | Dermatol Pract Concept. 2024;14(4):4566 6. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a com- prehensive review. J Am Acad Dermatol. 2009;60(4), 539-561. DOI: 10.1016/j.jaad.2008.11.911. 7. Patel KR, Lee HH, Rastogi S, et al. Association between hidrad- enitis suppurativa, depression, anxiety, and suicidality: a system- atic review and meta-analysis. J Am Acad Dermatol. 2020; 83(3): 737-744. DOI: 10.1016/j.jaad.2019.11.068. 8. de Souza DF, Wartchow K, Hansen F, et al. Interleukin-6- induced S100B secretion is inhibited by haloperidol and risperidone. Prog Neuropsychopharmacol Biol Psychiatry. 2013;43: 14-22. DOI: 10.1016/j.pnpbp.2012.12.001. 9. Van der Zee HH, de Ruiter L, Van Den Broecke DG, Dik WA, Laman JD, Prens EP. Elevated levels of tumour necrosis fac- tor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol. 2011;164(6), 1292-1298.  DOI: 10.1111/j.1365 -2133.2011.10254.x 10. Kohorst JJ, Kimball AB, Davis MD. Systemic associations of hidradenitis suppurativa.  J Am Acad Dermatol. 2015;  73(5), S27-S35. DOI: 10.1016/j.jaad.2015.07.055. 11. König A, Lehmann C, Rompel R, Happle R. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology. 1999; 198(3), 261-264. DOI: 10.1159/000018126. 12. Mackowick KM, Barr MS, Wing VC, Rabin RA, Ouellet- Plamondon C, George TP. Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems. Prog Neuropsychopharmacol Biol Psychiatry 2014;  52: 79-85. DOI: 10.1016/j.pnpbp.2013.07.010. 13. Caccavale S, Tancredi V, Boccellino MP, Babino G, Fulgione E, Argenziano G. Hidradenitis Suppurativa Burdens on Mental Health: A Literature Review of Associated Psychiatric Disorders and Their Pathogenesis. Life. 2023; 13(1), 189. DOI: 10.3390 /life13010189. 14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th ed.). 2013. DOI: 10.1176/appi .books.9780890425596. 15. Chou YJ, Tai YH, Dai YX, et al. Obsessive–compulsive disorder and the associated risk of autoimmune skin diseases: a nation- wide population-based cohort study. CNS Spectr. 2023; 28(2), 157-163. DOI: 10.1017/S1092852921000973. 16. Phan K, Huo Y R, Smith SD. Hidradenitis suppurativa and psy- chiatric comorbidities, suicides and substance abuse: systematic review and meta-analysis.  Ann Transl Med. 2020;  8(13):821. DOI: 10.21037/atm-20-1028. 17. Krajewski PK, Matusiak L, Von Stebut E, et al. Pain in hidrade- nitis suppurativa: a cross-sectional study of 1,795 patients. Acta Derm Venereol. 2021;101(1). DOI: 10.2340/00015555-3724. 18. Matusiak Ł, Szczęch J, Kaaz K, Lelonek E, Szepietowski JC. Clin- ical characteristics of pruritus and pain in patients with hidrad- enitis suppurativa. Acta Derm Venereol. 2018; 98(2), 191-194. DOI: 10.2340/00015555-2815. 19. Puza CJ, Wolfe SA, Jaleel T. Pain management in patients with hi- dradenitis suppurativa requiring surgery.  Dermatologic Surgery. 2019;45(10),1327-1330. DOI: 10.1097/DSS.0000000000001693. 20. Bair M J, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Archives of internal med- icine. 2003;163(20),2433-2445. DOI: 10.1001/archinte.163.20 .2433. 21. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13(3):595-605.  the appropriate treatment, although this was not confirmed by the present study [41]. An explanation could be that all patients had a large discrepancy between the onset and di- agnosis of the disease, therefore the data were homogeneous, and this is why there were no statistically significant differ- ences. Additionally, the lack of a relationship may be due to the fact that when the sample was taken, all patients were receiving appropriate treatment and had adequate knowledge of the disease, so any mental or physical burden they had felt in the past would have been compensated for at the time of the study, and they would not have responded while being burdened. Regarding pain and its correlation with most scales of psychopathology, this is an expected outcome as, based on the international literature, pain is among the most important problems of HS patients [17], since it affects up to 97% of pa- tients [18]. In fact, painful and smelly abscesses contribute to low self-esteem, avoidance of social interaction, and feelings of hopelessness, which trigger the appearance of psychopa- thology [42]. Meanwhile, the correlation with the neuroticism scale identified with histrionic personality could be due to the acting-out behaviors that are the structural feature of the dis- order, something which may be triggered by pain. In any case, due to the absence of research, further investigation is needed. Conclusion As can be seen from the present study and from the previous ones, there should be better education, both in the medical community and in the general population, because suffer- ers endure for many years the symptoms of a disease they cannot identify and receive inappropriate treatments due to both dermatologists’ and other medical specialties’ not mak- ing a correct differential diagnosis. References 1. Fabrazzo M, Cipolla S, Signoriello S, et al. A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidrade- nitis suppurativa. J Eur Psychiatry.  2021 Nov 25;64(1):e71. DOI: 10.1192/j.eurpsy.2021.2249. 2. Gooderham M, Papp K. The psychosocial impact of hidrade- nitis suppurativa. J Am Acad Dermatol. 2015;73(5), S19-S22. DOI: 10.1016/j.jaad.2015.07.054. 3. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a com- prehensive review.  J Am Acad Dermatol. 2009;60(4), 539-561. DOI: 10.1016/j.jaad.2008.11.911. 4. Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen AD. Psychiatric comorbidities in 3207 patients with hidradenitis sup- purativa. J Eur Acad Dermatol Venereol. 2015; 29(2):371-376. DOI: 10.1111/jdv.12567. 5. Sabat R, Jemec GB, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers.  2020 Mar 12;6(1):18. DOI: 10.1038/s41572-020-0149-1. Original Article | Dermatol Pract Concept. 2024;14(4):4566 11 33. Huilaja L, Tiri H, Jokelainen J, Timonen M, Tasanen, K. Patients with hidradenitis suppurativa have a high psychiatric disease burden: a Finnish nationwide registry study. J Invest Dermatol- ogy. 2018;138(1), 46-51. DOI: 10.1016/j.jid.2017.06.020. 34. Rymaszewska J, Krajewski P, Szczęch J, Szepietowski J. Depression and anxiety in hidradenitis suppurativa patients: A cross-sectional study among Polish patients. Postępy Dermatol Alergol. 2022; 39(1). DOI: 10.5114/ada.2022.119080. 35. Wolk K, Join-Lambert O, Sabat R. Aetiology and pathogene- sis of hidradenitis suppurativa.  Br J Dermatol.   2020;183(6): 999-1010. DOI: 10.1111/bjd.19556. 36. Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa.  Nat Rev Dis Primers. 2020;6(1):18. Published 2020 Mar 12. DOI: 10.1038/s41572-020-0149-1. 37. Kouris A, Platsidaki E, Christodoulou C, et al. Quality of Life and Psychosocial Implications in Patients with Hidradenitis Suppurativa. Dermatology. 2016;232(6):687-691. Doi: 10.1159 /00045335. 38. Gooderham M, Papp K. The psychosocial impact of hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5), S19-S22. DOI: 10.1016/j.jaad.2015.07.054. 39. Aslan S, Ersoy R, Kuruoglu AC, Karakoc A, Cakir N. Psychiatric symptoms and diagnoses in thyroid disorders: a cross-sectional study. Int J Psychiatry in Clinical Practice. 2005; 9(3), 187-192. DOI: 10.1080/13651500510029129. 40. Shlyankevich J, Chen AJ, Kim GE, Kimball AB. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Derma- tol. 2014;71(6), 1144-1150. DOI: 10.1016/j.jaad.2014.09.012. 41. Saunte DM, Boer J, Stratigos A. Diagnostic delay in  hidrad- enitis  suppurativa is a global problem. Br J Dermatol. 2015 Dec;173(6):1546-9. Doi: 10.1111/bjd.14038. Epub 2015 Nov 3. 42. Dufour DN, Emtestam L, Jemec GB. Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease.  Postgrad Med J. 2014;  90(1062), 216-221. DOI: 10.1136/postgradmedj-2013-131994. 22. Donias, S.; Karastergiou, A.; Manos, N. Validation of the Symp- tom Checklist- 90-R in Greek Population. Psychiatriki.  1991, 2, 42–48. DOI: 10.5431/aramit0209. 23. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An in- ventory for measuring depression. Arch Gen Psychiatry. 1961;4: 561-571. DOI: 10.1001/archpsyc.1961.01710120031004. 24. Eysenck HJ, Eysenck SBG.  Manual of the EPQ (Personality Questionnaire) Hodder and Stoughton Educational; Hodder & Stoughton Educational: London, UK, 1975. 25. Dimitriou, E. EPQ Personality Questionnaire. Greek Validation in the Greek Population Dimitriou E. Engefalos. 1986, 23, 41–54. 26. Melzack R. The short-form McGill Pain Questionnaire. Pain. 1975;1(3), 277-299. DOI: 10.1016/0304-3959(75)90044-5. 27. Horváth B, Janse IC, Blok JL et al. Hurley staging refined: a pro- posal by the Dutch Hidradenitis Suppurativa Expert Group. Acta Derm Venereol. 2017; 97(3):412-413. DOI: 10.2340/00015555 -2513. 28. Zouboulis CC, Tzellos T, Kyrgidis A, et al. European Hidrade- nitis Suppurativa Foundation Investigator Group Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol. 2017; 177(5), 1401-1409. DOI: 10.1111/bjd.15748. 29. Carniciu S, Hafi B, Gkini MA, Tzellos T, Jafferany M, Stamu- O’Brien C. Secondary psychiatric disorders and the skin. Derma- tological Reviews. 2023 :4(4), 162-171. DOI: 10.1002/der2.211. 30. Esmann S, Jemec GB. Psychosocial impact of hidradenitis sup- purativa: a qualitative study. Acta Derm Venereol. 2011; 91(3), 328-332. DOI: 10.2340/00015555-1082. 31. Onderdijk A J, Van der Zee HH, Esmann S et al. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2013; 27(4): 473-478. DOI: 10.1111/j.1468-3083 .2012.04468.x. 32. Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen AD. Psychiatric comorbidities in 3207 patients with hidradenitis sup- purativa. J Eur Acad Dermatol Venereol. 2015;29(2), 371-376. DOI: 10.1111/jdv.12567.